SAB Biotherapeutics Correlations

SABS Stock

USD 3.07 0.01 0.33%

The current 90-days correlation between SAB Biotherapeutics and Anebulo Pharmaceuticals is 0.36 (i.e., Weak diversification). The correlation of SAB Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

SAB Biotherapeutics Correlation With Market

Significant diversification

The correlation between SAB Biotherapeutics and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SAB Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy SAB Stock please use our How to Invest in SAB Biotherapeutics guide.

Moving together with SAB Stock

0.77

MDGL

Madrigal Pharmaceuticals

Pair Corr

Moving against SAB Stock

0.59	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.59	MTEM	Molecular Templates	Pair Corr
0.57	TPST	Tempest Therapeutics	Pair Corr
0.55	ME	23Andme Holding	Pair Corr
0.52	PFE	Pfizer Inc Fiscal Year End 4th of February 2025	Pair Corr
0.52	AGL	agilon health	Pair Corr
0.51	IPSC	Century Therapeutics	Pair Corr
0.49	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.48	NKTX	Nkarta Inc	Pair Corr
0.41	A	Agilent Technologies Earnings Call This Week	Pair Corr
0.38	TCHH	Trustcash Holdings	Pair Corr
0.34	VALN	Valneva SE ADR	Pair Corr
0.64	KO	Coca Cola Aggressive Push	Pair Corr
0.61	HYMTF	Hyundai Motor	Pair Corr
0.6	SHG	Shinhan Financial	Pair Corr
0.59	EC	Ecopetrol SA ADR	Pair Corr
0.59	WF	Woori Financial Group	Pair Corr
0.56	TLK	Telkom Indonesia Tbk	Pair Corr
0.51	PG	Procter Gamble	Pair Corr
0.33	BA	Boeing Fiscal Year End 29th of January 2025	Pair Corr

Related Correlations Analysis

	CMRA	PCSA	FRTX	THRD	CINGW	ANEB	CVKD	MNPR	UNCY
CMRA		0.18	-0.29	-0.28	0.1	0.04	-0.63	-0.24	-0.24	CMRA
PCSA	0.18		-0.53	0.01	0.64	0.62	-0.58	-0.72	-0.65	PCSA
FRTX	-0.29	-0.53		0.12	-0.41	-0.52	0.69	0.64	0.64	FRTX
THRD	-0.28	0.01	0.12		-0.2	0.22	0.52	0.25	0.55	THRD
CINGW	0.1	0.64	-0.41	-0.2		0.54	-0.48	-0.56	-0.59	CINGW
ANEB	0.04	0.62	-0.52	0.22	0.54		-0.36	-0.51	-0.34	ANEB
CVKD	-0.63	-0.58	0.69	0.52	-0.48	-0.36		0.74	0.76	CVKD
MNPR	-0.24	-0.72	0.64	0.25	-0.56	-0.51	0.74		0.75	MNPR
UNCY	-0.24	-0.65	0.64	0.55	-0.59	-0.34	0.76	0.75		UNCY
	CMRA	PCSA	FRTX	THRD	CINGW	ANEB	CVKD	MNPR	UNCY

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

UNCY	+ 0.76	CVKD
UNCY	+ 0.75	MNPR
MNPR	+ 0.74	CVKD
CVKD	+ 0.69	FRTX
CINGW	+ 0.64	PCSA
MNPR	+ 0.64	FRTX

High negative correlations

MNPR	- 0.72	PCSA
UNCY	- 0.65	PCSA
CVKD	- 0.63	CMRA
UNCY	- 0.59	CINGW
CVKD	- 0.58	PCSA
MNPR	- 0.56	CINGW

Risk-Adjusted Indicators

There is a big difference between SAB Stock performing well and SAB Biotherapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze SAB Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CMRA	5.99	(0.04)	0.00	(0.07)	0.00	0.00	13.95	(12.70)	30.28
PCSA	2.47	(0.87)	0.00	(0.85)	0.00	0.00	6.06	(5.34)	20.99
FRTX	4.93	0.58	0.08	1.15	5.64	(6.46)	7.84	(11.11)	49.60
THRD	3.44	(0.23)	(0.02)	0.01	4.86	(3.28)	8.35	(6.74)	25.76
CINGW	11.45	(0.13)	0.00	0.17	0.00	0.00	34.83	(25.20)	92.13
ANEB	5.22	(0.27)	0.00	(0.04)	0.00	0.00	8.85	(11.48)	76.00
CVKD	6.08	1.06	0.18	0.52	6.10	(6.99)	17.85	(7.47)	47.47
MNPR	20.54	10.43	0.90	(2.43)	7.94	(25.73)	15.93	(9.50)	653.56
UNCY	4.00	0.46	0.09	0.37	4.24	(5.20)	9.76	(7.41)	29.22

SAB Biotherapeutics Corporate Management

MBA CMA	Ex CFO	Profile
MD MBA	Executive Officer	Profile
Mark Conley	Interim Officer	Profile
Eddie Sullivan	President, CoFounder	Profile
Carlos Carillo	Senior Affairs	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC